[Changes in the coagulating and anticoagulating systems of the blood in uterine cervix cancer patients following administration of massive doses of thio-TEPA].
D000328:Adult; D000368:Aged; D001772:Blood Cell Count; D001778:Blood Coagulation Disorders / Q000139:chemically induced*; D001779:Blood Coagulation Factors / Q000032:analysis; D001780:Blood Coagulation Tests; D001791:Blood Platelet Disorders / Q000139:chemically induced; D005260:Female; D005341:Fibrinolysin / Q000032:analysis; D006801:Humans; D007272:Injections, Intralymphatic; D008875:Middle Aged; D013852:Thiotepa / Q000009:adverse effects*; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*
D001779:Blood Coagulation Factors; D013852:Thiotepa; D005341:Fibrinolysin
Izmeneniia svertyvaiushcheĭ i antisvertyvaiushcheĭ sistemy krovi u bol'nykh rakom sheĭki matki pri éndolimfaticheskom vvedenii udarnykh doz tio-TEFa.